Study Progression on Non-small Cell Lung Cancer with EGFR Mutation 
Treated by Immune Checkpoint Inhibitors

In recent years, epidermal growth factor receptor tyrosine kinase inhibitors have been recommended by many guidelines as first-line drugs for advanced non-small cell lung cancer (NSCLC) with EGFR gene mutations and no resistance. However, with the prolongation of medication time, most appear acquire...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Rilan BAI, Naifei CHEN, Jiuwei CUI
Format: Artigo
Sprog:Chinês
Udgivet: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-08-01
Serier:Chinese Journal of Lung Cancer
Fag:
Immune checkpoint inhibitors
Lung neoplasms
EGFR mutation
PD-L1
Online adgang:http://dx.doi.org/10.3779/j.issn.1009-3419.2018.08.11
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker